P. Schlenke et al., Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic, CYTOTECHNOL, 30(1-3), 1999, pp. 17-25
The human Golgi enzyme CMP-NeuAc:Gal(beta 1-4)GlcNAc-R alpha 2,6-sialyltran
sferase (ST6N) was stably coexpressed with human erythropoietin (EPO) from
a BHK-21A cell line. The cell line was characterized with respect to the ex
pression and in vitro activity of the ST6N and the endogenous alpha 2,3-sia
lyltransferase. Detailed structural analysis of the N- linked carbohydrates
of the rhuEPO expressed from the new cell line was performed by HPAE-PAD-m
apping, MALDI/TOF- MS and methylation analysis after purification of the re
combinant protein by immunoaffinity chromatography. This is the first repor
t describing that the human alpha 2,6-sialyltransferase is capable of sialy
lating, apart from Gal(beta 1-4)GlcNAc-R, also GalNAc(beta 1-4) GlcNAc-R mo
tifs in vivo, which is not the case for the endogenous BHK-cell alpha 2,3-s
ialyltransferase.